Healthcare
Switzerland
Biotech Research
Facility
Status: Active
Executive Overview
"Cutting-edge pharmaceutical research and clinical trials center"
A state-of-the-art biotechnology research facility focused on developing breakthrough treatments in oncology, neurology, and rare diseases. The facility houses advanced laboratory equipment and collaborates with leading pharmaceutical companies.
Operational Milestones
01
Facility construction completed
02
Research partnerships established
03
Clinical trials initiated
04
Regulatory approvals pending
Term Sheet
Funding Target
$80M
Min Allocation
$0M
Expected Yield
14-18% annually
Duration
12 years
Risk Class
Medium-High
Real-time project metrics available through our secure API Gateway.